Please login to the form below

Not currently logged in
Email:
Password:

Erelzi

This page shows the latest Erelzi news and features for those working in and with pharma, biotech and healthcare.

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

The US supreme court has decided not to review a patent case brought forward by Novartis’ generics division Sandoz for its Enbrel biosimilar Erelzi. ... Erelzi references Amgen’s blockbuster arthritis drug Enbrel (etanercept) – Sandoz had been

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...